Based on the above, as depicted in Fig. 9, our results show that TET activates autophagy in pancreatic cancer cells through the inhibition of the AKT/mTOR signaling pathway and modulates autophagy by promoting the transcription of ATG7. The gene discussed is AKT1; the disease is pancreatic neoplasm.